Article Details
Retrieved on: 2021-06-14 01:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Jubilant Pharma has signed a non-exclusive licensing agreement with Gilead Sciences Inc for the manufacturing and distribution of Remdesivir (API) ...
Article found on: www.outlookindia.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here